Financial Management Professionals’s Jazz Pharmaceuticals JAZZ Stock Holding History

Financial Management Professionals’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$964	Hold	4	–	–	﹤0.01%	868
2026 Q1	$756	Buy	4 +1	+33%	+$175	﹤0.01%	838
2025 Q4	$510	Buy	+3	New	+$460	﹤0.01%	872
2023 Q2	–	Sell	-4	Closed	-$1K	–	1023
2023 Q1	$1K	Hold	4	–	–	﹤0.01%	897
2022 Q4	$1K	Buy	+4	New	+$586	﹤0.01%	828
2022 Q3	–	Sell	-2	Closed	–	–	1016
2022 Q2	$0	Buy	+2	New	+$308	﹤0.01%	1033
2021 Q3	–	Sell	-4	Closed	-$1K	–	995
2021 Q2	$1K	Buy	+4	New	+$693	﹤0.01%	784
2016 Q3	–	Sell	-57	Closed	-$8K	–	366
2016 Q2	$8K	Buy	+57	New	+$8.4K	﹤0.01%	235

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Financial Management Professionals's JAZZ Position: Q2 2026 in Review

Financial Management Professionals held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 4 shares worth $964. The position accounts for ﹤0.01% of the portfolio, ranked #868.

Financial Management Professionals first reported a position in JAZZ in Q2 2016 and has held it in 8 quarters since. The position peaked at $8K in Q2 2016. 89 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Financial Management Professionals held 4 shares of Jazz Pharmaceuticals worth $964 as of Q2 2026.
Financial Management Professionals left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #868 holding.
Financial Management Professionals first reported a position in Jazz Pharmaceuticals in Q2 2016 and has held it in 8 quarters since.
Financial Management Professionals's Jazz Pharmaceuticals position peaked at $8K in Q2 2016.
89 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.